+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Constrained Peptide Drugs Market by Peptide Type, End-User - Global Forecast 2025-2030 - Product Thumbnail Image

Constrained Peptide Drugs Market by Peptide Type, End-User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 183 Pages
  • Global
From
Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • February 2023
  • 1359 Pages
  • Global
From
Epilepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Thumbnail Image

Epilepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • February 2025
  • 240 Pages
  • Global
From
Osteoporosis Drugs Market Report by Product Type, Route of Administration, and Region 2024-2032 - Product Thumbnail Image

Osteoporosis Drugs Market Report by Product Type, Route of Administration, and Region 2024-2032

  • Report
  • August 2024
  • 141 Pages
  • Global
From
Lennox-Gastaut Syndrome Treatment Market 2024-2028 - Product Thumbnail Image

Lennox-Gastaut Syndrome Treatment Market 2024-2028

  • Report
  • January 2024
  • 161 Pages
  • Global
From
Epilepsy Therapeutic Market in APAC 2024-2028 - Product Thumbnail Image

Epilepsy Therapeutic Market in APAC 2024-2028

  • Report
  • January 2024
  • 156 Pages
  • Asia Pacific
From
Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030 - Product Thumbnail Image

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

  • Report
  • February 2020
  • 360 Pages
  • Global
From
Epidural Abscess Treatment Market Report 2025 - Product Thumbnail Image

Epidural Abscess Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Restless Legs Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Restless Legs Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • November 2022
  • 205 Pages
  • Global
From
Crohn's Disease (CD) Treatment Market Report 2025 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Autoimmune Treatment Market Report 2025 - Product Thumbnail Image

Autoimmune Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 159 Pages
  • Global
From
Progressive Supranuclear Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Progressive Supranuclear Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 85 Pages
  • Global
From
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 1079 Pages
  • Global
From
Primary Immune Deficiency (PID) - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Immune Deficiency (PID) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Antiepileptic Drugs (AED) Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Antiepileptic Drugs (AED) Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Systemic Lupus Erythematosus - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 816 Pages
  • Global
From
Parkinson's Disease Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Parkinson's Disease Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 115 Pages
  • Global
From
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Huntington's Disease Treatment Market Analysis & Forecast 2024-2034: Market By Drug; By Treatment; By End-user; and By Region - Product Thumbnail Image

Huntington's Disease Treatment Market Analysis & Forecast 2024-2034: Market By Drug; By Treatment; By End-user; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Loading Indicator